$0.01 EPS Expected for CafePress Inc. (PRSS); Soleno Therapeutics (SLNO) Shorts Lowered By 37.43%

February 11, 2018 - By Linda Rogers

Analysts expect CafePress Inc. (NASDAQ:PRSS) to report $0.01 EPS on March, 6.They anticipate $0.19 EPS change or 95.00% from last quarter’s $0.2 EPS. PRSS’s profit would be $168,625 giving it 36.00 P/E if the $0.01 EPS is correct. After having $-0.22 EPS previously, CafePress Inc.’s analysts see -104.55% EPS growth. The stock decreased 2.03% or $0.03 during the last trading session, reaching $1.44. About 126,593 shares traded or 269.40% up from the average. CafePress Inc. (NASDAQ:PRSS) has declined 17.19% since February 11, 2017 and is downtrending. It has underperformed by 33.89% the S&P500.

Soleno Therapeutics Incorporated (NASDAQ:SLNO) had a decrease of 37.43% in short interest. SLNO’s SI was 46,300 shares in February as released by FINRA. Its down 37.43% from 74,000 shares previously. With 27,200 avg volume, 2 days are for Soleno Therapeutics Incorporated (NASDAQ:SLNO)’s short sellers to cover SLNO’s short positions. The stock increased 7.69% or $0.12 during the last trading session, reaching $1.68. About 219,840 shares traded or 23.96% up from the average. Soleno Therapeutics, Inc. (NASDAQ:SLNO) has 0.00% since February 11, 2017 and is . It has underperformed by 16.70% the S&P500.

Soleno Therapeutics, Inc. focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company has market cap of $32.32 million. The companyÂ’s lead candidate, diazoxide choline controlled-release , a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is entering into Phase II/III clinical development. It currently has negative earnings. It also markets medical devices, including the CoSense End-Tidal Carbon Monoxide (ETCO) monitor, which measures ETCO and is used by hospitals to detect hemolysis in newborns; and NeoPip T-piece resuscitator and related consumables, which deliver consistent pre-set inspiratory pressure and positive end-expiratory pressures, as well as temperature probes, scales, surgical tables, and patient surfaces.

Investors sentiment decreased to 0.8 in 2017 Q3. Its down 0.11, from 0.91 in 2017Q2. It fall, as 4 investors sold CafePress Inc. shares while 6 reduced holdings. 4 funds opened positions while 4 raised stakes. 4.19 million shares or 158.31% more from 1.62 million shares in 2017Q2 were reported. Macquarie Gp Limited reported 20,110 shares. Vanguard Gru Inc stated it has 0% of its portfolio in CafePress Inc. (NASDAQ:PRSS). Jacobs Levy Equity Management holds 0% or 34,266 shares. Financial Bank Of America De stated it has 0% in CafePress Inc. (NASDAQ:PRSS). Dimensional Fund Advsrs Limited Partnership owns 28,562 shares. Spark Investment Mgmt Llc invested in 30,358 shares. Blackrock invested 0% of its portfolio in CafePress Inc. (NASDAQ:PRSS). Lpl Ltd accumulated 0% or 12,000 shares. Standard General L P reported 3.12% of its portfolio in CafePress Inc. (NASDAQ:PRSS). Moreover, Royal National Bank Of Canada has 0% invested in CafePress Inc. (NASDAQ:PRSS) for 9 shares. 19,500 were accumulated by California Pub Employees Retirement. Blackhill Cap Inc holds 99,969 shares. Morgan Stanley invested 0% of its portfolio in CafePress Inc. (NASDAQ:PRSS). Renaissance Technologies Ltd Liability Co holds 702,325 shares or 0% of its portfolio. Bridgeway Capital Management holds 0% or 134,588 shares.

Since September 20, 2017, it had 0 buys, and 2 insider sales for $5.08 million activity. SC XI MANAGEMENT LLC sold $5.03M worth of stock.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Linda Rogers

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: